Major NAD Supplement Trial SHOCKS Scientists. Now What?

🩺 Get your personalized health plan: https://drstanfield.com/health-67d 🍵 Potassium Fiber drink: https://potassiumfiber.com/yt-67d A year-long trial in Norway gave 410 people with early Parkinson's disease either nicotinamide riboside (NR) or a placebo, and the people on NR did WORSE. NR and nicotinamide mononucleotide (NMN) are sold to raise NAD, a molecule central to our metabolism, and the excitement came from a few mouse studies and the idea that NAD falls as we age. So far, raising NAD in the blood hasn't translated into people feeling or functioning any better, and this trial undercuts the idea that NR is, at worst, harmless. Timestamps: 00:00 NR Study Shock 01:18 Why NAD Boosters Got Hyped 02:51 Human Evidence Reality Check 04:56 Long COVID Trial Spin 06:55 High-dose Vitamin B3 Risks 08:24 The New NR & Parkinsons Tria 09:54 Results Worse Than Placebo 11:26 Why Might NR Backfire 12:57 NMN Likely No Different 13:59 Takeaways and Next Steps 📄 Full write-up & all the studies from this video: https://drstanfield.com/blogs/articles/concerning-nr-and-nmn-supplement-result ✔️ X: https://x.com/BradStanfieldMD ✔️ Patreon: https://www.patreon.com/bradstanfieldmd Video edited by Troy Young The content contained in this video, and its accompanying description, is not intended to replace viewers’ relationships with their own medical practitioner. Always speak with your doctor regarding the content of this channel, and especially before using any products, services, or devices discussed on this channel.